Chemo-induced myelosuppression can affect patients’ ability to do daily tasks, and management varies by patient, treatment ...

The addition of navtemadlin to ruxolitinib for JAK inhibitor-naive patients with myelofibrosis with suboptimal response to ...

On this episode of Onc Nurse On Call, Kristin Daly, MSN, ANP-BC, AOCNP, discusses practical cancer care strategies in the age ...

The FDA has granted approval to adjuvant cemiplimab treatment for patients with high-risk cutaneous squamous cell carcinoma ...

Jackson, the administrative director of advanced practice at the Vanderbilt-Ingram Cancer Centers in Franklin and Nashville, ...

A network to connect patients with unused medications with patients in need brought $18 million of free cancer medication ...

Panelists discuss how the subcutaneous nivolumab data demonstrate reassuring safety with minimal grade 3/4 events, how ...

AI-driven decision support can ease oncologists’ workloads and streamline care without reducing autonomy.

Oncology nurses can help patients and families understand the expectations of pediatric brain cancer survival, says Kasey Rangan, MSN, CPNP-PC, CPHON. In order for oncology nurses to provide ...

Panelists discuss the critical role of patient education and multidisciplinary coordination in managing immunotherapy side effects, emphasizing proactive symptom monitoring, timely communication, ...

UGN-102 has received FDA approval for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer. The FDA has approved mitomycin intravesical solution (UGN-102) for the ...

"This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with multiple myeloma as seen in clinical practice. The ...